Summary
Tyrosine hydroxylase is considered to be the rate-limiting enzyme in the synthesis of catecholamines in both the central and peripheral nervous system. Increased or decreased neuronal activity, stress, lesions, drug effects, endocrinological manipulations and experimental models of hypertension are associated with alterations in tyrosine hydroxylase activity in the central nervous system. In many of these instances, the changes in the activity of tyrosine hydroxylase in the central nervous system that occur are localized to discrete catecholaminergic pathways and nuclei in the brain. The purpose of this review is to summarize and assess this information and to provide insight into the function of catecholamine systems in the brain and their interactions with other putative neurotransmitter systems.
Similar content being viewed by others
References
Weiner, N., 1975. The Basic Neurosciences; The Nervous System (Brady, R. O., ed.), Vol. 1, pp. 341–354, Raven Press, New York.
Levitt, M., Spector, S., Sjoerdsma, A. and Udenfriend, S., 1965. J. Pharmacol. Exp. Ther. 148: 1–8.
Weiner, N., Lee, F.-L., Dreyer, E. and Barnes, E., 1978. Life Sci. 22: 1197–1216.
Morgenroth, V. H., III, Boadle-Biber, M. and Roth, R. H., 1974. Proc. Natl. Acad. Sci. 71: 4283–4287.
Roth, R. H., Morgenroth, V. H., III and Salzman, P. M., 1975. Naunyn-Schmiedeberg's Arch. Pharmacol. 289: 327–343.
Masserano, J. M. and Weiner, N., 1979. Mol. Pharmacol. 16: 513–528.
Masserano, J. M. and Weiner, N., 1981. Life Sci. 29: 2025–2029.
Masserano, J. M. and Weiner, N., 1981. Regulation and Function of Monoamine Enzymes (Usdin, E., Weiner, N. and Youdim, M. B. H., eds.), pp. 75–81, Macmillan, London.
Zivkovic, B., Guidotti, A. and Costa, E., 1974. Mol. Pharmacol. 10: 727–735.
Lovenberg, W. and Bruckwick, E. A., 1975. Psychopharmacol. Bull. 11: 11–12.
Lovenberg, W., Bruckwick, E. A. and Hanbauer, I., 1975. Proc. Natl. Acad. Sci. 72: 2955–2958.
Andrews, D. W., Langan, T. A. and Weiner, N., 1983. Proc. Natl. Acad. Sci. U.S.A., in press.
Kuczenski, R. T. and Mandell, A. J., 1972. J. Neurochem. 19: 131–137.
Lloyd, T. and Kaufman, S., 1974. Biochem. Biophys. Res. Comm. 59: 1261–1269.
Raese, J. R., Patrick, L. and Barchas, J. D., 1976. Biochem. Pharmacol. 25: 2245–2250.
Katz, I. R., Yamauchi, T. and Kaufman, S., 1976. Biochim. Biophys. Acta 429: 84–95.
Nagatsu, T., Numata, Y., Kato, T., Sugiyama, K. and Akino, M., 1978. Biochim. Biophys. Acta 523: 47–52.
Kurosawa, A., Guidotti, A., and Costa, E., 1979. Mol. Pharmacol. 15: 115–130.
Kurosawa, A., Guidotti, A. and Costa, E., 1976. Science 193: 691–693.
Weiner, N., 1979. Aromatic Amino Acid Hydroxylases and Mental Disease (Youdim, M. B. H., ed.), pp. 141–190, John Wiley and Sons Ltd.
Weiner, N., 1970. Ann. Rev. Pharmacol. 10: 273–290.
Mandell, A. J., 1978. Ann. Rev. Pharmacol. Toxicol. 18: 461–493.
Falck, B., Hillarp, N. A., Thieme, G. and Thorp, A., 1962. J. Histochem. Cytochem. 10: 348–354.
Dahlstrom, A. and Fuxe, K., 1964. Acta Physiol. Scand. 62, Suppl. 232: 1–55.
Ungerstedt, U., 1971. Acta Physiol. Scand. Suppl. 367: 1–48.
Livett, B. G., 1973. Br. Med. Bull. 29: 93–99.
Kobayashi, R. R. M., Palkovits, M., Kopin, I. J. and Jacobowitz, D. M., 1974. Brain Research 77: 269–279.
Zigmond, R. E. and Ben-Ari, Y., 1977. Proc. Natl. Acad. Sci. U.S.A. 74: 3078–3080.
Roth, R. H., Salzman, P. M. and Morgenroth, V. H., III, 1974. Biochem. Pharmacol. 23: 2779–2784.
Salzman, P. M. and Roth, R. H., 1980. J. Pharmacol. Exp. Ther. 212: 64–73.
Murrin, C., Morgenroth, V. H., III and Roth, R. H., 1976. Mol. Pharmacol. 12: 1070–1081.
Schlehuber, C. J., Segal, D. S. and Spooner, C. E., 1975. Brain Research 91: 341–347.
Walters, J. R., Aghajanian, G. K. and Roth, R. H., 1972. Proceedings of the Fifth International Congress on Pharmacology, Abstract 1472, p. 246.
Walters, J. R. and Roth, R. H., 1974. J. Pharmacol. Exp. Ther. 191: 82–91.
Tarda, C., 1975. Pharmac. Biochem. Behav. 3: 735–738.
Farjo, I. B. and Blackwood, D. H. R., 1978. Brain Research 153: 423–426.
Ross, R. A., Tong, H. J. and Reis, D. J., 1975. Brain Research 92: 57–72.
Buda, M., Roussel, B., Renaud, B. and Pujol, J.-F., 1975. Brain Research 93: 564–569.
Morgenroth, V. H., III, Walters, J. R. and Roth, R. H., 1976. Biochem. Pharmacol. 25: 655–661.
Reis, D. J., Gilad, G., Pickel, V. M. and Joh, T. H., 1978. Brain Research 144: 325–342.
Gilad, G. and Reis, D. J., 1978. Brain Research 149: 141–153.
Ross, R. A. and Reis, D. J., 1981. Exp. Neurol. 73: 571–575.
Bloom, F. E., Algeri, S.; Groppetti, A., Revuelta, A. and Costa, E., 1969. Science 166: 1284–1286.
Uretsky, N. J. and Iversen, L. L., 1970. J. Neurochem. 17: 269–278.
Breese, G. R. and Taylor, T. D., 1970. J. Pharmacol. Exp. Ther. 174: 413–420.
Acheson, A. L., Zigmond, M. J. and Stricker, E. M., 1980. Science 207: 537–540.
Acheson, A. L. and Zigmond, M. J., 1981. J. Neuroscience 1: 493–504.
Thoenen, H., 1970. Nature 228: 861–862.
Chuang, D., Zsilla, G. and Costa, E., 1975. Mol. Pharmacol. 11: 784–794.
Kvetnansky, R., Weise, V. K. and Kopin, I. J., 1970. Endocrinology 87: 744–749.
Masserano, J. M., Takimoto, G. S. and Weiner, N., 1981. Science 214: 662–665.
Gilad, G. M. and McCarty, R., 1981. Brain Research 206: 239–243.
Palkovits, M., Kobayashi, R. M., Kizer, J. S., Jacobowitz, D. M. and Kopin, I. J., 1975. Neuroendocrinology 18: 144–153.
Lamprecht, F., Eichelman, B., Thoa, N. B., Williams, R. B. and Kopin, I. J., 1972. Science 177: 1214–1215.
Zigmond, R. E., Schorr, F. and Iversen, L. L., 1974. Brain Research 70: 547–552.
Tissar, A. H., Argiolas, A., Fadda, F., Serra, G. and Gessa, G. L., 1979. Naunyn-Schmiedeberg's Arch. Pharmacol. 308: 155–157.
Stone, E. A., Freedman, L. S. and Margano, L. E., 1978. Pharmacol. Biochem. Behav. 9: 551–553.
Weiss, J. M., Glazer, H. I., Pohorecky, L. A., Brick, J. and Miller, N. E., 1975. Psychomatic Med. 37: 522–534.
Raab, A. and Oswald, R., 1980. Physiol. Behav. 24: 387–394.
Musacchio, J. M., Julou, L., Kety, S. S. and Glowinski, J., 1969. Proc. Natl. Acad. Sci. 63: 1117–1119.
Tiplady, B., Killian, J. J. and Mandel, P., 1976. Life Sci. 18: 1065–1070.
Boarder, M. R., Feldon, J., Gray, J. A. and Filleny, M., 1979. Neurosci. Letters 15: 211–215.
Zivkovic, B. and Guidotti, A., 1974. Brain Research 79: 505–509.
Zivkovic, B., Guidotti, A., Revuelta, A. and Costa, E., 1975. J. Pharmacol. Exp. Ther. 194: 37–46.
Zivkovic, B., Guidotti, A. and Costa, E., 1975. Chemical Tools in Catecholamine Research (Almgren, O., Carlsson, A. and Engel, J., eds.), Vol. II, pp. 45–52, North-Holland Publishing Co., Amsterdam.
Guidotti, A., 1980. Adv. Biochem. Psychopharmacol. 24: 1–8.
Zivkovic, B., Guidotti, A. and Costa, E., 1975. J. Pharm. Pharmac. 27: 359–360.
Stoff, D. M. and Gale, K., 1981. Brain Research 211: 492–496.
Bunney, B. S., Walters, J. R., Roth, R. H. and Aghajanian, G. K., 1973. J. Pharmacol. Exp. Ther. 185: 560–571.
Aghajanian, G. K. and Bunney, B. S., 1977. Naunyn-Schmiedeberg's Arch. Pharmacol. 297: 1–7.
Roth, R. H., 1973. Nature 245: 123–125.
Zivkovic, B., Guidotti, A. and Costa, E., 1975. Naunyn-Schmiedeberg's Arch. Pharmacol. 291: 193–200.
Bjorklund, A. and Lindvall, O., 1975. Brain Research 83: 531–537.
Korf, J., Zieleman, M. and Westernik, B. H. C., 1976. Nature 260: 257–258.
Tissari, H. A., Porceddu, M. L., Argiolas, A., DiChiara, G. and Gessa, G. L., 1978. Life Sci. 23: 653–658.
McGeer, E. G., Innane, V. T. and McGeer, P. L., 1976. Brain Research 118: 356–358.
Schwarz, R. and Coyle, J. T., 1977. Brain Research 127: 235–249.
Waggoner, W. G., McDermed, J. and Leighton, H. J., 1980. Mol. Pharmacol. 18: 91–99.
Quik, M., Emson, P. C. and Joyce, E., 1979. Brain Research 167: 355–365.
Gale, K. N. and Guidotti, A., 1976. Nature 263: 691–693.
Guidotti, A. and Gale, K., 1977. Adv. Biochem. Psychopharmacol. 16: 455–460.
Fonnum, F., Grofova, I., Rinvik, E., Storm-Mathesen, J. and Walberg, F., 1974. Brain Research 71: 71–92.
Gale, K., Howg, J.-S. and Guidotti, A., 1977. Brain Research 136: 371–375.
Precht, W. and Yoshida, M., 1971. Brain Research 32: 229–233.
Gale, K. and Casu, M., 1981. Mol. Cell. Biochem. 39: 369–405.
Gale, K., Costa, E., Toffano, G., Howg, J.-S. and Guidotti, A., 1978. J. Pharmacol. Exp. Ther. 206: 29–37.
Hong, J. S., Yang, H.-Y. T., Racagni, G. and Costa, E., 1977. Brain Research 122: 541–544.
Walker, R. V., Kemp, J. A., Yajima, H., Kitagawa, K. and Woodruff, G. N., 1976. Experientia 32: 214–215.
Casu, M. and Gale, K., 1981. J. Pharmacol. Exp. Ther. 217: 177–180.
Lerner, P., Nose, P., Gordon, E. K. and Lovenberg, W., 1977. Science 197: 181–183.
Lovenberg, W., Alphs, L., Pradshan, S., Bruckwick, E. and Levine, R., 1980. Adv. Biochem. Psychopharmacol. 24: 9–15.
Pradhan, S., Alphs, L. and Lovenberg, W., 1981. Neuropharmacol. 20: 149–154.
Guidotti, A., Gale, K., Toffano, G. and Vargas, F. M., 1978. Life Sci. 23: 501–506.
Gale, K., 1980. Adv. Biochem. Psychopharmacol. 24: 23–29.
Tissari, A. H., Casu, M. and Gessa, G. L., 1979. Life Sci. 24: 411–416.
Bacopoulos, N. G., Bustos, G., Redmond, D. E., Banlu, J. and Roth, R. H., 1978. Brain Research 157: 396–401.
Bacopoulos, N. G., Bustos, G., Redmond, D. E. and Roth, R. H., 1982. J. Pharmacol. Exp. Ther. 221: 22–28.
Weiner, N., 1980. The Pharmacological Basis of Therapeutics (Goodman, L. S. and Gilman, A., eds.) p. 202, Macmillan Publishing Col., Inc., New York.
Mueller, R. A., Thoenen, H, and Axelrod, J., 1969. J. Pharmacol. Exp. Ther. 169: 74–79.
Segal, D. S., Sullivan, J. L., III, Kuczenski, R. T. and Mandell, A., 1971. Science 27: 847–849.
Reis, D. J., Job, T. H., Ross, R. A. and Pickel, V. M., 1974. Brain Research 81: 380–386.
Reis, D. J., Job, T. H. and Ross, R. A., 1975. J. Pharmacol. Exp. Ther. 193: 775–784.
Black, I. B., 1975. Brain Research 95: 170–176.
Zigmond, R. E., 1979. J. Neurochem. 32: 23–29.
Sorimachi, M., 1975. Brain Research 99: 400–404.
Renaud, B., Job, T. H., Snyder, D. W. and Reis, D. J., 1979. Brain Research 176: 169–174.
Carr, L. A. and Moore, K. E., 1969. Science 164: 322–323.
Fibiger, H. C. and McGeer, E. G., 1971. Eur. J. Pharmacol. 16: 176–180.
Mandell, A. J., Knapp, S., Kuczenski, R. T. and Segal, D. S., 1972. Biochem. Pharmacol. 21: 2737–2750.
Hulme, E. C., Hill, R., North, M. and Kibby, M. R., 1974. Biochem. Pharmacol. 23: 1393–1404.
Kogan, F. J., Nichols, W. K. and Gibb, J. W., 1976. Eur. J. Pharmacol. 36: 363–371.
Koda, L. Y. and Gibb, J. W., 1973. J. Pharmacol. Exp. Ther. 185: 42–48.
Buening, M. K. and Gibb, J. W., 1974. Eur. J. Pharmacol. 26: 30–34.
Bakhit, C., Kwok, Y. C. and Gibb, J. W., 1980. Life Sci. 26: 1815–1819.
Gibb, J. W. and Kugan, F. J., 1979. Naunyn-Schmiedeberg's Arch. Pharmacol. 310: 185–187.
Hotchkiss, A. J., Morgan, M. E. and Gibb, J. W., 1979. Life Sci. 25: 1373–1378.
Hotchkiss, A. J. and Gibb, J. W., 1980. J. Pharmacol. Exp. Ther. 214: 257–262.
Bardsley, M. E. and Bachelard, H. S., 1981. Biochem. Pharmacol. 30: 1543–1549.
Ellison, G., Eison, M. S., Huberman, H. S. and Daniel, F., 1978. Science 201: 276–278.
Ulus, I. H. and Wurtman, R. J., 1976. Science 194: 1060–1061.
Richardson, J. S., Lamprecht, F., Kazic, T. and Kopin, I. J., 1976. Can. J. Physiol. Pharmacol. 54: 774–778.
Lewander, T., Job, T. H. and Reis, D. J., 1975. Nature 258: 440–441.
Lewander, T., Joh, T. H. and Reis, D. J., 1977. J. Pharmacol. Exp. Ther. 200: 523–534.
Renaud, B., Job, T. H., Snyder, D. W. and Reis, D. J., 1979. Brain Research 176: 169–174.
Sullivan, J. L., Segal, D. S., Kuczenski, R. T. and Mandell, A. J., 1972. Biological Psychiatry 4: 193–203.
Peters, D. A. V. and Mazurkiewicz-Kwilecki, 1975. J. Pharm. Pharmacol. 27: 671–676.
Hockfelt, B., Hedeland, H. and Dymling, J.-F., 1970. Eur. J. Pharmacol. 10: 389–397.
Geyskes, G. G., Boen, P. and Dorhount Mess, E. J., 1979. Br. J. Clin. Pharmacol. 7: 55–62.
Dix, R. K. and Johnson, E. M., 1977. Eur. J. Pharmacol. 44: 153–159.
Kane, W. H. and Johnson, E. M., 1978. Eur. J. Pharmacol. 51: 309–312.
DiStefano, P., Fox, G. and Johnson, E. M., 1980. J. Pharmacol. Exp. Ther. 214: 263–268.
Gysling, K. and Roth, R. H., 1981. Function and Regulation of Monoamine Enzymes: Basic and Clinical Aspects (Usdin, E., Weiner, N. and Youdim, M., eds.) Macmillan Pub. Ltd., London.
French, T. A., Masserano, J. M. and Weiner, N., 1983. J. Pharm. Pharmacol., in press.
Smith, R. C., Taylor, D., Ho, B. T. and Leelavathi, D. E., 1980. J. Neural Transmission 48: 289–295.
Ho, B. T., Taylor, D. and Englert, L. F., 1973. Res. Comm. Chem. Pathol. Pharmacol. 5: 851–854.
Peters, D. A. V. and Tang, S., 1977. J. Neurochem. 28: 59–62.
Cicero, T. J., Wilcox, C. E., Smithloff, B. R., Meyer, E. R. and Sharpe, L. G., 1973. Biochem. Pharmacol. 22: 3237–3246.
Branchey, L., Bodner, S. and Friedhoff, A. J., 1974. Res. Comm. Chem. Pathol. Pharmacol. 8: 707–710.
Bonnet, K. A., Branchey, L. B., Friedhoff, A. J. and Ehrlich, Y. H., 1978. Life Sci. 22: 2003–2008.
Reis, D. J., Hess, P. and Azrnitia, E. C., 1970. Brain Research 20: 309–312.
Branchey, L. and Friedhoff, A. J., 1973. Psychopharmacologia 32: 151–156.
Detering, W., Edwards, E. Ozand, P. and Karahasan, A., 1980. J. Neurochem. 34: 297–304.
Baizer, L., Masserano, J. M. and Weiner, N., 1981. Pharmacol. Biochem. Behav. 15: 945–949.
Masserano, J. M., Takimoto, G. S. and Weiner, N., 1983. Exp. Clin. Res., in press.
Leger, L. and Descarries, L., 1978. Brain Research 145: 1–13.
Pickel, V., Joh, T. H. and Reis, D. J., 1977. Brain Research 131: 197–214.
Renaud, B., Buda, M., Lewis, B. D. and Pujol, J-F., 1975. Biochem. Pharmacol. 24: 1739–1742.
McRae-Degueurce, A. and Pujol, J-F., 1979. Eur. J. Pharmacol. 59: 131–135.
Keane, P. E., Degueurce, A., Renaud, B., Crespi, F. and Pujol, J. F., 1978. Neurosci. Letters 8: 151–158.
Crespi, F., Buda, M., McRae-Degueurce, A. and Pujol, J-F., 1980. Brain Research 191: 501–509.
Lewis, B. D., Renaud, B., Buda, M. and Pujol, J.-F., 1976. Brain Research 108: 339–340.
McRae-Degueurce, A., Berod, A., Mermet, A., Keller, A., Chouvet, G., Joh, T. H. and Pujol, J.-F., 1982. Brain Research 235: 285–301.
Werblin, F. S. and Dowling, J. E., 1969. J. Neurophysiol. 32: 339–355.
Kramer, S. G., 1971. Invest. Opthol. 10: 438–452.
Iuvone, P. M., Galli, C. L., Garrison-Fund, C. K. and Neff, N. H., 1978. Science 202: 901–902.
Marshburn, P. B. and Iuvone, P. M., 1981. Brain Research 217: 335–347.
Iuvone, P. M., Galli, C. L. and Neff, N. H., 1978. Mol. Pharmacol. 14: 1212–1219.
Iuvone, P. M., Job, T. H. and Neff, N. H., 1979. Brain Research 178: 191–195.
Cohen, J., Iuvone, P. M. and Neff, N. H., 1981. J. Pharmacol. Exp. Ther. 218: 390–394.
Cohen, J. and Neff, N. H., 1982. J. Pharmacol. Exp. Ther. 221: 326–328.
Kalra, S. P. and McCann, S. M., 1973. Endocrinology 93: 356–362.
Kordon, C. and Glowinski, J., 1972. Neuropharmacology 11: 153–162.
Dickerman, S., Clark, J., Dukerman, E. and Meites, J., 1972. Neuroendocrinology 9: 332–340.
Maickel, R. P., Westermann, E. O. and Brodie, B. B., 1961. J. Pharmacol. Exp. Ther. 134: 167–175.
Kizer, J. S., Palkovits, M., Zivin, J., Brownstein, M., Saavedra, J. M. and Kopin, I. J., 1974. Endocrinology 95: 799–812.
Dunn, A. J., Gildersleeve, N. B. and Gray, A. E., 1978. J. Neurochem. 31: 977–982.
Rastogi, R. B. and Singhal, R. L., 1974. Brain Research 81: 243–266.
Nakahara, T., Uchimura, H., Hirano, M., Saito, M., Kim, J. S. and Matsumoto, T., 1979. Brain Research 179: 396–400.
Kizer, J. S., Muth, E. and Jacobowitz, D. M., 1976. Endocrinology 98: 886–893.
Nakahara, T., Uchimura, H., Hirano, M., Saito, M. and Ito, M., 1976. Brain Research 117: 351–356.
Beattie, C. W. and Martin, M. M., 1976. Experientia 15: 1076–1077.
Beattie, C. W., Rodgers, C. H. and Soyka, L. F., 1972. Endocrinology 91: 276–279.
Beattie, C. W. and Soyka, L. F., 1973. Endocrinology 93: 1443–1455.
Luine, V. N., McEwen, B. S. and Black, I. B., 1977. Brain Research 120: 188–192.
Lloyd, T. and Weisz, J., 1978. J. Biol. Chem. 253: 4841–4843.
Lloyd, T. and Ebersole, B. J., 1980. J. Neurochem. 34: 726–731.
Carr, L. A. and Voogt, J. L., 1980. Brain Research 196: 437–445.
Voogt, J. L. and Carr, L. A., 1981. Proc. Soc. Exp. Biol. Med. 166: 277–281.
Tobias, H., Carr, L. A. and Voogt, J. L., 1981. Life Sci. 29: 711–716.
Ben-Ishay, D., Saliternik, R. and Welner, A., 1972. Experientia 28: 1321–1322.
Feuerstein, G., Zamir, N., Ben-Ishay, D. and Gutman, Y., 1979. J. Neurochem. 33: 393–395.
Saavedra, J. J., Grabecker, H. and Axelrod, J., 1978. Circulat. Res. 42: 529–534.
Versteeg, D. H. G., Dalkovits, M., Van der Gugten, J., Wijnen, H. L. J. M., Smeets, G. W. M. and De Jong, W., 1973. Brain Research 61: 235–252.
Nagatsu, T., Ikuta, K., Numata, Y., Kato, T. and Sano, M., 1976. Science 191: 290–291.
Nagatsu, T., Kato, T., Numata, Y., Ikuta, K., Sane, M., Nagatsu, I., Umezawa, H., Matsuzaki, M. and Takeuchi, T., 1977. Japan J. Pharmacol. 27: 531–535.
Renaud, B., Job, T. H. and Reis, D. J., 1969. Brain Research 173: 164–167.
Nagaoka, A. and Lovenberg, W., 1977. Eur. J. Pharmacol. 43: 297–306.
Rylett, P., Dean, H. G. and Lee, M. R., 1976. J. Pharm. Pharmacol. 28: 559–562.
Jackson, N., Gulliver, P. A. and Dean, H. G., 1981. J. Pharm. Pharmacol. 33: 445–450.
Petty, M. A. and Reid, J. L., 1978. Clin. Sci. Mol. Med. 55: 1015–1035.
Petty, M. A. and Reid, J. L., 1979. Brain Research 163: 277–288.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Masserano, J.M., Weiner, N. Tyrosine hydroxylase regulation in the central nervous system. Mol Cell Biochem 53, 129–152 (1983). https://doi.org/10.1007/BF00225250
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00225250